Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Long-Term Capital Lease Obligation : ¥3 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Shenzhen New Industries Biomedical Engineering Co Long-Term Capital Lease Obligation?

Shenzhen New Industries Biomedical Engineering Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥3 Mil.

Shenzhen New Industries Biomedical Engineering Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (¥4 Mil) to Dec. 2023 (¥3 Mil) and declined from Dec. 2023 (¥3 Mil) to Mar. 2024 (¥3 Mil).

Shenzhen New Industries Biomedical Engineering Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (¥1 Mil) to Dec. 2022 (¥1 Mil) and increased from Dec. 2022 (¥1 Mil) to Dec. 2023 (¥3 Mil).

Shenzhen New Industries Biomedical Engineering Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Shenzhen New Industries Biomedical Engineering Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen New Industries Biomedical Engineering Co Long-Term Capital Lease Obligation Chart

Shenzhen New Industries Biomedical Engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.20

0.88

0.89

3.49

Shenzhen New Industries Biomedical Engineering Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.98	0.89	3.87	3.49	3.25

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Shenzhen New Industries Biomedical Engineering Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shenzhen New Industries Biomedical Engineering Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen New Industries Biomedical Engineering Co Ltd (SZSE:300832) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 23, Jinxiu East Road, Kengzi Street, 21st Floor, New Industrial Bio Building, Jinsha Community, Pingshan District, Guangdong Province, Shenzhen, CHN, 518000

Website

http://www.snibe.com

Shenzhen New Industries Biomedical Engineering Co Ltd is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. The company produces and sells series of automatic chemiluminescence immunoassay instruments and supporting reagents. Its products include Immunoassay, Clinical Chemistry, Integrated System, Lab Automation, and Reagents.

Executives

Ma Jie	Supervisors
Ding Chen Liu	Executives
Zhang Xiao Hong	Executives
Zhang Lei	Directors, executives
Li Ting Hua	Executives
Liu Hai Yan	Executives
Song Hong Tao	Supervisors
Liu Peng	Director
Jiang Li Li	Supervisors

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Headlines

No Headlines